Dr. Md. Alimur Reza clinical trial pipeline

2 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 0 with minor changes only.

1. Stopped

   Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus…Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

   Trial status changed: Recruiting → Withdrawn

   Sponsor's reason: Withdrawn by the sponsor before any participant was enrolled. Protocol-specified screening and randomization were not initiated at the study site. Not related to participant safety.

   Dr. Md. Alimur Reza·Phase 4· NCT06789432· Registry history of NCT06789432 on ClinicalTrials.gov (opens the registry)

   Updated Oct 7, 2026

2. Notable

   Tirzepatide · Obesity With or Without Type 2 Diabetes Mellitus…Tirzepatide · Obesity With or Without Type 2 Diabetes Mellitus (T2DM)

   Primary completion pushed from Apr 2026 to Oct 2027

   Also in this update: Completion pushed from Jul 2026 to Dec 2027

   Dr. Md. Alimur Reza·Not specified· NCT07099742· Registry history of NCT07099742 on ClinicalTrials.gov (opens the registry)

   Updated Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.